SC
TMCI icon

Steven Cohen’s Treace Medical Concepts TMCI Stock Holding History

Steven Cohen’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-169,792
Closed -$416K – 4501
2025
Q4 		$416K Buy
+169,792
New +$737K ﹤0.01% 3329
2025
Q1 		– Sell
-190,100
Closed -$1.41M – 2533
2024
Q4 		$1.41M Buy
+190,100
New +$1.27M ﹤0.01% 1374
2024
Q3 		– Sell
-362,710
Closed -$2.41M – 2346
2024
Q2 		$2.41M Buy
+362,710
New +$2.93M 0.01% 1044
2023
Q4 		– Sell
-1,252,628
Closed -$16.4M – 2821
2023
Q3 		$16.4M Sell
1,252,628
-165,916
-12% -$3.04M 0.05% 465
2023
Q2 		$36.3M Buy
1,418,544
+1,065,992
+302% +$27.5M 0.11% 237
2023
Q1 		$8.88M Sell
352,552
-43,154
-11% -$1.01M 0.03% 576
2022
Q4 		$9.1M Buy
395,706
+100,275
+34% +$2.31M 0.03% 583
2022
Q3 		$6.52M Buy
295,431
+75,236
+34% +$1.46M 0.03% 634
2022
Q2 		$3.16M Buy
220,195
+8,435
+4% +$142K 0.01% 820
2022
Q1 		$4M Buy
211,760
+177,410
+516% +$3.45M 0.02% 751
2021
Q4 		$640K Buy
+34,350
New +$709K ﹤0.01% 952

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steven Cohen's TMCI Position: Q1 2026 in Review

Steven Cohen sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 169,792 shares — an estimated $416K sold.

Steven Cohen first reported a position in TMCI in Q4 2021 and held it in 11 quarters. The position peaked at $36.3M in Q2 2023. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Steven Cohen reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Steven Cohen sold 169,792 Treace Medical Concepts shares in Q1 2026, an estimated $416K.
  • Steven Cohen first reported a position in Treace Medical Concepts in Q4 2021 and held it in 11 quarters.
  • Steven Cohen's Treace Medical Concepts position peaked at $36.3M in Q2 2023.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.